Saturday 14 November 2026 Daily emailMarket analysisEnterpriseVigiEye regulatory newsCompePharma CRM & HR →
Market analysisEnterprise
The business of pharma
Subscribe free
Approvals & launches

FDA approves NDA221291, a new medicine

Bayer Healthcare; NDA221291; New molecular entity, Priority review

09 Nov 2026 · FDA · Approval

Official record: FDA ↗

Written by CompePharma's editorial system from the official record. AI-assisted; check the source before acting. Not investment advice.

More Approvals & launchesAll →